Home

cap trial

High dose vitamin C 'ineffective' in treating Covid-19, but statin  beneficial | NIHR
High dose vitamin C 'ineffective' in treating Covid-19, but statin beneficial | NIHR

Seven- to eight-year follow-up of the CoolCap trial of head cooling for  neonatal encephalopathy | Pediatric Research
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research

REMAP-CAP
REMAP-CAP

CAP - Trial Practice, Second Edition (9780769855332). Authors: Michael  Martin, Paul Radvany, Lawrence Dubin, Thomas F. Guernsey. Carolina Academic  Press
CAP - Trial Practice, Second Edition (9780769855332). Authors: Michael Martin, Paul Radvany, Lawrence Dubin, Thomas F. Guernsey. Carolina Academic Press

Momentum 3 Trial - CAP Publication | Abbott
Momentum 3 Trial - CAP Publication | Abbott

REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube
REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube

ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to –  ASCOT: The Australasian COVID-19 Trial
ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial

The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM -  Emergency Medicine Blog
The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM - Emergency Medicine Blog

How long should we treat children with pneumonia for? - the results of CAP-IT  - Don't Forget the Bubbles
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles

Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch  adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised,  non-inferiority, antimicrobial stewardship intervention trial - The Lancet  Infectious Diseases
Narrow-spectrum antibiotics for community-acquired pneumonia in Dutch adults (CAP-PACT): a cross-sectional, stepped-wedge, cluster-randomised, non-inferiority, antimicrobial stewardship intervention trial - The Lancet Infectious Diseases

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line

Changing Perceptions of Phase 1 Cancer Clinical Trials - NCI
Changing Perceptions of Phase 1 Cancer Clinical Trials - NCI

REMAP-CAP Trial
REMAP-CAP Trial

DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]
DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]

Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial -  CureDuchenne
Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial - CureDuchenne

Celebrating REMAP – CAPs success on International Clinical Trials Day –  ACTA – Australian Clinical Trials Alliance
Celebrating REMAP – CAPs success on International Clinical Trials Day – ACTA – Australian Clinical Trials Alliance

How long should we treat children with pneumonia for? - the results of CAP-IT  - Don't Forget the Bubbles
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line

Background — REMAP-CAP Trial
Background — REMAP-CAP Trial

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community  Acquired Pneumonia (ATTACC-CAP ) | Trial or Study
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study

Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent  Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking  Clinical Trials
Grand Rounds August 11, 2023: The REMAP-CAP Adaptive Platform Trial: Recent Insights and Future Directions (Patrick Lawler, MD, MPH) - Rethinking Clinical Trials

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial

CAP trial design. *Further n = 1451 excluded due to prostate cancer... |  Download Scientific Diagram
CAP trial design. *Further n = 1451 excluded due to prostate cancer... | Download Scientific Diagram